• Bradford Protein Assay Kit: Rapid, Sensitive Protein Quantif

  2026-04-24

  The Bradford Protein Assay Kit (SKU K4103) provides a straightforward, rapid solution for accurate protein quantification in research workflows where high sensitivity and quick turnaround are essential. It is best applied to assays requiring reliable concentration measurements from small samples and is not suited for use with protein samples containing interfering detergents or chemicals not supported by the Bradford chemistry.

• Cimetidine (SKU B1557): Reliable Solutions for Cell Assays

  2026-04-24

  This article provides an evidence-based, scenario-driven exploration of Cimetidine (SKU B1557) for cell viability, proliferation, and cytotoxicity assays. Addressing real laboratory challenges, it demonstrates how Cimetidine’s unique pharmacological profile, high purity, and robust solubility from APExBIO support reproducible and sensitive experimental workflows.

• Degarelix Acetate in Prostate Cancer: Rapid Castration Witho

  2026-04-23

  The reference study establishes degarelix acetate as a third-generation GnRH antagonist that enables rapid and sustained medical castration in prostate cancer patients, circumventing the testosterone surge commonly seen with GnRH agonists. Its safety and efficacy profile positions degarelix as a significant advance in androgen deprivation therapy, supporting precision in clinical management.

• Thiothixene in Macrophage Efferocytosis: Pathways and Resear

  2026-04-23

  Explore how the typical antipsychotic agent Thiothixene uniquely drives in vitro macrophage efferocytosis via vitamin A signaling, with profound implications for both schizophrenia treatment and immunology research. This article uncovers advanced mechanistic insights and practical assay guidance.

• Innovations in In Vitro Drug Response Evaluation for Cancer

  2026-04-22

  Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drugs in vitro by distinguishing between relative and fractional cell viability. This dual-metric approach provides nuanced insights into how compounds like Axitinib (AG 013736) modulate proliferation and cell death, improving the predictive value of preclinical models for cancer therapy.

• Imeglimin Enhances Mitochondrial Function in CTS SSCT Cells

  2026-04-22

  This study demonstrates that Imeglimin improves mitochondrial function and reduces oxidative stress in subsynovial connective tissue-derived cells from patients with idiopathic carpal tunnel syndrome. These findings support the role of mitochondrial health in disease progression and highlight new avenues for targeted interventions.

• Molecular Epidemiology and Pathogenicity of C. auris in Guan

  2026-04-21

  This study provides one of the first comprehensive molecular epidemiological analyses of Candidozyma auris isolates in South China, detailing clade distribution, antifungal resistance mechanisms, and virulence factors. Findings inform local infection control strategies and highlight methodological approaches applicable to emerging multidrug-resistant fungal pathogens.

• Pepstatin A in Modern Research: Precision Inhibition and New

  2026-04-21

  Explore how Pepstatin A, a leading aspartic protease inhibitor, is reshaping cardiovascular and cellular research with advanced mechanistic insights. This article delivers a comprehensive, evidence-driven perspective not found in standard guides.

• SP2509: Lysine-Specific Demethylase 1 Antagonist for AML Res

  2026-04-20

  SP2509 is a highly selective Lysine-specific demethylase 1 antagonist that empowers researchers to dissect and therapeutically target cancer epigenetics, especially in acute myeloid leukemia. This article provides actionable workflows, troubleshooting guidance, and comparative advantages to accelerate translational discovery.

• CD28-ARS2 Axis Drives PKM Splicing for T Cell Metabolic Flex

  2026-04-20

  Holling et al. reveal that CD28 signaling in CD8+ T cells upregulates ARS2, which orchestrates alternative splicing of pyruvate kinase (PKM), favoring the PKM2 isoform and enabling metabolic flexibility essential for antitumor immunity. These findings clarify a critical mechanism by which T cells adapt their metabolism, with implications for immunotherapy and metabolic profiling.

• Escitalopram in Translational Neuroscience: Strategy & Mecha

  2026-04-19

  Explore how Escitalopram (Lexapro) advances antidepressant and anxiolytic research. This article blends mechanistic insights with strategic guidance for translational scientists, referencing the latest clinical findings, robust protocol parameters, and APExBIO’s high-purity Escitalopram’s unique value. Go beyond standard product pages with a vision for next-generation serotonergic research.

• Chronic 40 Hz Light Flicker Attenuates Epileptogenesis via d

  2026-04-18

  This study demonstrates that chronic 40 Hz light flicker (GENUS) can reduce epileptogenesis in a mouse model by strengthening gamma oscillations through a defined visual circuit involving the dorsal lateral geniculate nucleus (dLGN) shell. The findings highlight a non-invasive approach to modulate neuronal networks relevant for epilepsy, with implications for circuit-specific research and chemogenetic modulation strategies.

• 2,5-di-tert-butylbenzene-1,4-diol: Optimizing SERCA Inhibiti

  2026-04-17

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) from APExBIO stands out as a robust, selective SERCA inhibitor, empowering next-generation calcium signaling and stem cell mobilization assays. This article provides actionable workflow protocols, troubleshooting insights, and advanced application strategies for bench researchers seeking reproducibility and translational impact.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-04-16

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly sensitize tumors to ultra-high dose rate FLASH radiotherapy by boosting reactive oxygen species and DNA double-strand breaks, resulting in improved antitumor effects and immune activation. The work provides a mechanistic rationale and preclinical evidence for combining radiosensitizing nanoparticles with FLASH-RT to overcome its current limitations in tumor control.

• Coumestrol: Phytoestrogen Estrogen Receptor Antagonist in RA

  2026-04-15

  Coumestrol stands out as a selective phytoestrogen estrogen receptor antagonist, offering researchers a robust tool for dissecting nuclear receptor pathways and inducing ferroptosis in autoimmune models. This article translates the latest mechanistic findings into practical workflows, troubleshooting guidance, and protocol optimizations for leveraging Coumestrol (SKU C5832, APExBIO) in advanced selective estrogen receptor modulator (SERM) studies.

15655 records 1/1044 page Next 12345 下5页 Last page